• Cypher Genomics Signs Deal with Illumina, Expands Executive Team

    Bio-IT World News Brief | Cypher Genomics yesterday announced a sales deal with Illumina and added a host of new players to executive board positions.

    Jul 25, 2014

  • With $650 Million Gift, Psychiatric Disorders Once Again in Limelight at the Broad

    Bio-IT World | Ted Stanley, the philanthropist whose 2007 gift of $100 million formed the basis of the Stanley Center for Psychiatric Research at the Broad Institute, has pledged an additional $650 million to the center.

    Jul 23, 2014

  • Berry Genomics, Illumina Seek Chinese Regulatory Approval for NIPT

    Bio-IT World News Brief | Berry Genomics has chosen Illumina next-generation sequencing (NGS) technology as the platform on which Berry hopes to secure Chinese Food and Drug Administration (CFDA) regulatory approval for clinical applications. The combined "system" is in late stage CFDA testing, the Chinese company says.

    Jul 21, 2014

  • Roche Planning to Stay Out of Acquisitions

    Reuters | Roche is staying out of the pharma merger and acquisition fray, the CEO said. "We're sticking to our previous strategy... [of] small acquisitions and partnerships."

    Jul 21, 2014

  • Universal Language: The Pistoia Alliance Takes on Indescribable Biology

    Bio-IT World | The Pistoia Alliance received a Best Practices Award at this year's Bio-IT World Conference & Expo for its work on HELM, a project that establishes a standard notation for complex macromolecules that are too large to sketch out atomically, but too heterogeneous to express as chains of RNA or amino acids. The project will aid interoperability across the industry, as pharma companies increasingly rely on strange, hybrid biochemistry in creating new therapeutics.

    Jul 18, 2014

  • Could CRISPR Transform Wild Ecosystems?

    Bio-IT World | In a paper published yesterday in the open access journal eLife, George Church and colleagues discuss the potential for "gene drives" that alter the genomes of whole wild populations using CRISPR gene editing technology, and weigh the risks and public interests surrounding such initiatives.

    Jul 18, 2014

  • Illumina Acquires Regulatory Strategy Consulting Firm

    Bio-IT World News Brief | Illumina today announced its acquisition of Myraqa, a consulting firm specializing in the regulatory strategy surrounding in vitro diagnostics, particularly companion diagnostics.

    Jul 16, 2014

  • Novartis Signs On to License Google's Glucose-Monitoring Contact Lenses

    New York Times | Google and Novartis have announced a partnership for Novartis to license Google's smart contact lens that could measure a wearer's blood sugar levels.

    Jul 16, 2014

  • IBM Gains Ground with SoftLayer Cloud

    Computerworld | IBM is gaining cloud ground with its SoftLayer product, Big Blue says, reporting 6,000 new customers in the last year and $1.2 billion invested in data centers.

    Jul 15, 2014